05:06 PM EDT, 06/25/2025 (MT Newswires) -- Reviva Pharmaceuticals ( RVPH ) disclosed on Wednesday plans for a public offering of its common shares and warrants, subject to market and other conditions.

The pharmaceutical company did not specify the size or pricing of the proposed offering.

Reviva said proceeds would be used to fund research and development activities, working capital, and other general corporate purposes.

Shares of Reviva were down more than 29% in after-hours activity.